Consequently, the elevated AKR1B10 promotes a glycolytic phenotype in cholangiocarcinoma (CCA) cells, characterized by increased glucose uptake and lactate production, which ultimately drives malignant progression74. Here, AKR1B10 is linked to cholangiocarcinoma.